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Abstract
Purpose of review Here we review the latest literature and
evidence in the field of genetics and determinants of
swallowing and its treatments—specifically, this is a very
recent concept in the field of oropharyngeal dysphagia,
with only now an emerging research interest in the rela-
tionship between our genetic makeup and the effect this has
on swallowing function and dysfunction. As such our
review will look at preclinical, clinical and hypothesis
generating research covering all aspects of the genetics of
swallowing, giving new importance to the genotype-phe-
notype influences pertaining to dysphagia and its recovery.
Recent findings There appear to be a number of candidate
gene systems that interact with swallowing or its neuro-
physiology, which include brain-derived neurotrophic
factor, apolipoprotein E and catechol-O-methyltransferase,
that have been shown to impact on either swallowing
function or the brain’s ability to respond to neurostimula-
tion and induce plasticity. In addition, a number of genetic
disorders, where dysphagia is a clinical phenomenon, have
given us clues as to how multiple genes or the polygenetics
of dysphagia might interact with our swallowing
phenotype.
Summary There is currently limited research in the field of
genetic factors that influence (human) swallowing and
oropharyngeal dysphagia, but this is an emerging science
and one which, in the future, may herald a new era in
precision medicine and better targeting of therapies for
dysphagia based on an individual’s genetic makeup.
Keywords Dysphagia  Swallowing  Genes 
Polymorphism
Introduction
Dysphagia is a common symptom among ‘‘healthy’’ elderly
and frail individuals. Increased numbers of cases with
dysphagia are being observed among residents of care
homes (up to 52.5 %) and hospital units compared with
those who live in their own homes (from 13 %) [1, 2].
Other at-risk groups include patients with neurodegenera-
tive disorders such as Parkinson’s disease (with up to 85 %
incidence of dysphagia) [3], patients with stroke (20–63 %
incidence of dysphagia) [4, 5–7] and patients with chronic
neurological conditions including multiple sclerosis, head
injury, amyotrophic lateral sclerosis, and myasthenia
gravis [8]. The discrepancies between prevalence data on
dysphagia may result from a number of factors including
patient demographic differences, method of identification
and diagnosis of dysphagia and differences in study design
such as interventional versus observational studies. More-
over, patients with dysphagia reveal different recovery
patterns [7], which often impact on the effectiveness of
existing therapies. The factors that influence both the
propensity for dysphagia, its recovery and response to
treatment remain unclear but it seems increasingly likely
that an individual’s genetic make-up may play an important
role in these processes. Indeed, one of the key drivers in
recovery from swallowing impairments is change in
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neuronal excitability within the swallowing motor cortex
[9]. Cortical neuronal excitability associated with swal-
lowing performance remains an area of interest and again is
thought to be influenced by genetic factors.
Hence, knowledge about the features of an individual’s
genotype has the potential for developing novel treatment
strategies within stratified medicine. Stratified medicine
(also called personalised or precision medicine) is an
approach which subdivides patients into groups based on
their risk of developing specific diseases/symptoms or their
response to particular treatment therapies.
There are a number of ways to explore complex disease/
symptoms [10]. One of the first steps is classification of the
disease/symptom as heritable, usually after conducting
family or twin studies. Unfortunately, no twin studies on
swallowing processes have been done to date. However,
cortical excitability remains a significant avenue for
exploration of genetic propensity. Twin studies have shown
that cortical excitability (a plausible driver in the recovery
of dysphagia following neurologic damage) induced by
non-invasive brain stimulation delivered over the hand
motor cortex might have a genetic component. The heri-
tability estimate for brain motor excitability was 0.68,
which means 68 % of the variance can be explained by
genetics [11]. A similar phenomenon is likely to occur in
the swallowing motor system.
The following review will therefore present the current
state of knowledge on the genetic background of swal-
lowing processes from both human and animal studies,
where individual genes, single nucleotide polymorphisms
(SNPs) or chromosomal regions have been examined. The
existing literature highlights a number of single genes or
SNPs which might take a part in the human and animal
swallowing neurophysiology. Additionally, genetic syn-
dromes, in which one of the features is dysphagia, will be
explored. These studies provide information on chromo-
somal localisation of genes which may take a part in the
process of impaired swallowing development. This review
will mainly focus on oropharyngeal dysphagia rather than
oesophageal impairments which most likely have different
aetiologies.
Genetics of swallowing in humans
One of the novel treatment approaches for swallowing
problems is the application of (non-invasive) brain stimu-
lation to influence the swallowing motor cortex and mea-
sure responses with motor evoked potentials (MEPs) and
assess behaviour with videofluoroscopy (VFS) and/or
questionnaires. One such technique is repetitive Transcra-
nial Magnetic Stimulation (rTMS) where either high- or
low-frequency regimens are used to modulate swallowing
motor cortex. Studies on healthy volunteers showed that
high-frequency rTMS delivered over the pharyngeal motor
cortex increases excitability measured with MEPs
[12, 13, 14••] and low frequency decreases the excitability
[14••, 15]. The exact mechanisms of plasticity remain
unknown; however, both frequencies were used in clinical
trials to improve swallowing performance [9, 16–21].
Neurostimulation studies conducted on healthy volun-
teers provide a useful tool to explore the genetics of
swallowing neurophysiology and reactiveness for treat-
ments and recovery. Certain genes may predispose indi-
viduals to display expected or unexpected outcomes from
stimulation. No studies have been done on stroke patients
with regard to exploring their genetic predispositions to
outcomes from rTMS interventions; however, studies
conducted in healthy volunteers might provide information
of potential genetic markers of swallowing
neurophysiology.
The first study exploring the genetic basis of neurolog-
ical control of swallowing was conducted by Jayasekeran
et al. [14••]. The study focused on an SNP from the BDNF
gene ((Online Mendelian Inheritance in Man (OMIM)
number: 113505)). The main aim of the study was to find
an association between Val66Met (rs6265) SNP and its
impact on the pharyngeal muscle responses followed by 1
and 5 Hz rTMS paradigms and pharyngeal electrical
stimulation (PES). The BDNF gene is located on the
chromosome 11, locus 11p13 and is a member of the nerve
growth factor family. BDNF is expressed by cortical neu-
rons, and is necessary for survival of striatal neurons in the
brain. Multiple studies showed that rs6265 from the BDNF
gene affects cortical plasticity and motor responses in both
healthy adults and patients with brain lesions [22–24, 25•,
26]. Polymorphism rs6265 located in the coding region of
the BDNF causes substitution of valine (Val) to methionine
(Met) in the codon 66.
Jayasekeran et al. [14••] showed a link between provoked
neuronal plasticity of the pharyngeal area and the impact of
the polymorphism rs6265. As an outcome, MEPs from the
pharyngeal muscles were collected with an intra-luminal
catheter placed in the individual’s throat. The individuals
were divided into two groups according to their genotype
from the codon 66 of BDNF: Val/Val and non-Val/Val
(carrying Val/Met of Met/Met) groups. Statistical analysis
showed significant differences between the pharyngeal
MEPs in homozygous participants with Val/Val comparing
to participants carrying at least one BDNF Met allele after
5 Hz rTMS. This study suggests the plausible hypothesis of a
genetic factor in pharyngeal cortical plasticity. Jaysekeran’s
et al. studywas the first to use a humanmodel of this nature to
study swallowing neurophysiology and genetics. The main
disadvantage of this research was the examination of the
single-gene polymorphism, since the majority of common
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diseases are most likely multifactorial and polygenic (com-
plex) that may include gene–gene or gene–environmental
interactions [27].
Of relevance, BDNF rs6265 status may also affect
oesophageal sensitivity induced by electrical stimulation.
Another study by Vasant et al. [28] used electrical stimu-
lation of the oesophagus of healthy subjects to measure
sensitivity and its association with rs6265. The study
explored the relationship between oesophageal sensitivity
and BDNF rs6265 genotype and found that Met allele
carriers were more likely to have lower levels of sensory
tolerance to oesophageal electrical stimulation. The results
were independent of self-reported anxiety and depression
scores.
Preliminary results from Essa et al. [29] described a
possible association between BDNF rs6265 and response to
pharyngeal electrical stimulation (PES) in stroke patients’
population. The authors suggested that active PES in the
presence of the BDNF Met allele might play a role in
improvement of swallowing function at the 3-month stage
as compared to non-Met allele.
Another field of research delivers a more comprehensive
approach in exploring genetic basis of swallowing
impairments. These are population studies where a more
general phenotype of swallowing is used. Self-reported
swallowing questionnaires about swallowing symptoms
related to dysphagia are especially useful in the early
screening of both patients and healthy individuals in the
early stages of swallowing problems.
Mentz et al. [30] performed the first association analysis
between self-reported swallowing symptoms from the
(University of Manchester’s) Dyne Steel Cohort of heathy
elderly volunteers and the APOE gene (OMIM number:
107741). The APOE gene encodes apolipoprotein which is
essential for normal catabolism of triglyceride-rich
lipoprotein constituents. It has been discovered that iso-
forms of APOE are related to neurological conditions and
cognitive decline [31–33]. This study used a more global
approach, assessing 634 elderly volunteers. Volunteers
completed a self-reported Sydney Swallow Questionnaire
(SSQ) concerning the presence of swallowing problems.
The score was classified as clinically significant if the
obtained value C120. The study showed that there was an
association between APOE E4 homozygosity and higher
scores from the SSQ questionnaire. The main advantage of
the study was the number of individuals included, which
gives a better statistical power of the result.
Another study conducted on 538 participants with self-
reported swallowing problems was performed by Nimmons
et al. [34]. The researchers again used the Dyne Steel
cohort. However, the analysis explored two genes: 12 SNPs
from BDNF and 18 SNPs from COMT gene. COMT gene
(OMIM 116790; cytogenetic location: 22q11.21) encodes
the protein which catalyses the inactivation of cate-
cholamine neurotransmitters and catechol hormones.
COMT protein shortens the biological half-lives of certain
neuroactive drugs such as L-dopa [35]. Interestingly, the
status of two interactive SNPS from COMT polymorphism
rs165599 and the BDNF polymorphism rs10835211 was
shown to predict dysphagia in this cohort of elderly indi-
viduals. This finding shows the complexity of interactions
between genes which might affect swallowing neurophys-
iology in health and disease.
The most recent study in this literature used, for the first
time, a more global approach and analysed over 500,000
SNPs from across the genome and their association with
swallowing problems from individuals from the same well-
characterised Dyne Steel Cohort [36••]. This analysis
showed one SNP rs17601696 from an area of unknown
function appeared to influence self-reported swallowing
status. Genome-wide association studies are a useful tool in
identifying possible genetic links and symptoms [10, 37].
One of the disadvantages of these studies is the need of
replication of the results in multiple cohorts within differ-
ent populations to provide more robust results.
Self-reported questionnaires, despite lowered accuracy,
remain a useful tool for swallowing symptoms diagnosis.
However, there are disadvantages of this tool such as:
recall biases, silent aspiration, undetectable by individuals,
and response biases (although response rates in this work
were[80 %). Presented studies have predominantly used
only one longitudinal cohort for analysis, and therefore
replications in other cohorts are crucial. Studies conducted
on humans are briefly summarised in Table 1.
Genetics of swallowing—evidence from animal
studies
Methodological issues around recruitment and detailed
investigation and variability within the outcomes linked to
human studies make animal studies an informative source
of the genetic data associated with swallowing, in spite of
their limitations (summarised in Table 2).
Kurihara et al. [38] examined the influence of two
hydrolases encoded by genes UCHL1 (OMIM 191342) and
UCHL3 (OMIM 603090) on dysphagia in mice. The
authors reported that double-homozygous mice for both
UCHL1 and UCHL3 had a 45 % weight reduction com-
pared to the wild type which they used as a proxy for a
direct measurement of dysphagia. They used the method of
identification of undigested, but masticated food in the
animals’ cages. The loss of weight could have different
causes. A further limitation is that the authors examined
only the pathological changes in the nucleus tractus soli-
tarius (NTS), not examining the cerebral cortex. The
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presence of protein aggregation in the mouse’s brains
might be evidence of neurological causes of swallowing
impairments in these animals.
Other sources of potentially relevant genes have been
examined in animal studies where weight has been asses-
sed in Parkinson’s disease (PD) models. Over 80 % of PD
patients develop swallowing impairments. Despite the
developing diagnostic tools to measure swallowing
impairment in rodents, such as videofluoroscopy, these
techniques are not used in genetic studies of PD models in
rats. A recent study explored the effects of mice knockout
for PINK1 gene (OMIM 608309) [39]. Limb and voca-
tional function and neurodegenerative pathologies with
immunochemistry were examined. Among other findings,
the authors showed that, during the tongue protrusion task,
knockout for PINK1 gene rats had to use greater force in
the ‘licking challenge’ and showed more variable licking
patterns compared to wild-type rats. The main disadvan-
tage was lack of more accurate swallowing impairment
measures.
There are a number of studies exploring the effects of
protein products of BDNF, TRKB, OB, ERK genes on
swallowing physiology in rats [40–43].
The BDNF gene was examined in animal models, with
the linkage to TRKB gene (also called NTRK2) [40, 41].
TRKB (OMIM 600456) gene encodes a member of the
Table 1 Summary of studies exploring genetics of swallowing physiology in humans
Gene Technique Cohort Swallowing assessment Author












Sensory (ST) and pain (PT) thresholds in the proximal (PE)
and distal (DE) oesophagus






Validated dysphagia severity rating scale, recorded at
baseline, 2 weeks and 3 months post recruitment
Essa et al. [29]
APOE Association analysis Elderly
volunteers
Self-reported questionnaire Mentz et al. [30]
BDNF ? COMT Association analysis Elderly
volunteers









Table 2 Summary of studies exploring genetics of swallowing physiology in animals
Gene Technique Cohort Swallowing assessment Author
UCHL1
UCHL3
Mice homozygous for both genes Genetically
modified
mice
Presence of partially consumed,




PINK Knockout for PINK1 rats Adult Long-
Evans rats
Tongue force, biting Grant [41]
BDNF
TRKB
Injection of BDNF into the dorsal vagal complex and repetitive
electrical stimulation of the superior laryngeal nerve
Adult male
Wistar rats




Tongue exercise effects on neurotrophic factors in the cranial
sensorimotor system measured with immunoreactivity
Wistar rats Tongue press task,
immunoreactivity of TRKB












ERK Orofacial stimulation, immunohistochemical features in brainstem
neurons, brainstem lesioning and of microinjection of GABA





EMG activity was recorded Tsujimura
[43]
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neurotrophic tyrosine receptor kinase (NTRK) family.
Bariohay et al. [40] showed that BDNF inhibits the swal-
lowing reflex in rats. Injection of BDNF into the dorsal
vagal complex resulted in inhibition of regular swallowing
induced by electrostimulation. Moreover, the inhibition is
probably stimulated by the interaction of BDNF and
GABAegric interneurons and is associated with TRKB
activation. Bariohay’s studies overlook the impact of cor-
tical areas while focusing only on the dorsal vagal complex
(DVC) and its effect on swallowing. Other limitations
include methodological problems in clearly showing that
dysphagia in the rat is homologous to humans. The author’s
conclusions were based on the presence of masticated, but
not digested, food in the rats’ cages.
Comparatively, Schaser et al. [41] in a rodent model
used 48 rats divided into three age groups. Immunocyto-
chemistry tests showed that immunoreactivity of TRKB in
the sensorimotor system decreases with age. Additionally,
BDNF expression increased after tongue pressure exer-
cises, but only in the young rats. Among the group of old
and middle-aged rats, there were no significant decreases of
immunochemistry of this protein. Moreover, there were no
significant increases in TRKB and BDNF expression after
tongue muscle exercises in old and middle-aged animals.
These studies were only preliminary and further, more
detailed investigation is needed.
Another protein which has been reported to possibly
affect swallowing control is leptin, encoded by the OB
gene. Leptin plays a role in the regulation of feeding
behaviour. Felix et al. [42] showed the inhibitory effect of
the OB gene (OMIM 164160) on swallowing in rats. The
results showed effects of leptin on the swallowing central
pattern generator (SwCPG) as well as motor neuron
activity (motor outputs). Dysphagia in rats was diagnosed
in the same way as in previous studies, that is, the presence/
absence of masticated, undigested food. In terms of limi-
tations, the authors were examining swallowing in general,
not specifically dysphagia; the effects on appetite were
excluded. Moreover, there has been no confirmation of
these studies since 2006.
Swallowing difficulties were also studied in terms of
orofacial pain that often occurs with dysphagia. Tsujimura
et al. [43] investigated the effects of orofacial stimulation
on the swallowing reflex, phosphorylated extracellular
signal-regulated kinase (pERK) within the area of the
nucleus tactus solitarius (NTS). Anaesthetised rats had
stainless steel wire electrodes placed in the mylohyoid
muscle to record EMG activity. Changes in swallowing
performance were assessed by laryngeal movement and by
mylohyoid electromyographic (EMG) activity. The find-
ings provided evidence that facial pathways between the
skin and NTS, as well as lingual muscles and the NTS,
might modulate the swallowing reflex. While this study
was not focused on the genetics of swallowing, it may
provide some evidence for involvement of the gene
encoding the pERK protein. As before, these studies
examined only the involvement of the brainstem and not
cortical areas in control of swallowing. A main advantage
of the study was the more reliable and detailed method of
swallowing assessment.
Animal studies from the field of neuroscience, despite
some cohort replication advantages, carry different kinds of
other disadvantages and, as such, interpretation of the
results should be made with caution. One of the potential
causes may be differences in brain structures even among
the same species [34]. One of the advantages of using rats
as the animal model is that they have a short life span
(36 months), allowing study of ageing-related physiologi-
cal changes, and responsiveness to different kinds of
interventions.
Despite the limitations, a significant proportion of
results from animal models can go on to replication in
human studies; therefore, replication of the genetic loci
from this work is warranted in future experimental work.
Genetic syndromes, where one of the features is
dysphagia
Dysphagia is a common symptom observed in congenital
genetic syndromes. Studies conducted on patients with
these genetic syndromes, where the detailed genetic
background is examined, may provide another source of
valuable information on swallowing genetics. The litera-
ture describing these complex genetic diseases could pro-
vide evidence about the chromosomal localisation of genes
which may play a role in swallowing difficulties.
The following sections exclude syndromes where
swallowing difficulties are caused by severe cleft palate
(frequently observed in Pierre Robin Syndrome), inappro-
priate mastication and eating quickly which can cause




Potocki–Lupski syndrome (PTLS) is caused by micro-du-
plication of chromosome 17p11.2 [dup(17)(p11.2p11.2)].
The phenotype is characterised by a number of dysmorphic
features, hypotonia, sleeping problems, cardiovascular
diseases and gaining insufficient weight. Moreover,
patients suffer from neurological and cognitive features
including intellectual impairment and autism. However,
not every patient presents all of these features. Genetically,
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patients have duplication of a region of the short arm of
chromosome 17.
Soler-Alfonso et al. [35] published studies about the
association of oropharyngeal dysphagia and failure to
thrive in PTLS. A limitation of this study was that swal-
lowing function data were available from only 18 patients
for study analysis. This is understandable, given that the
disease is extremely rare. Another limitation was the
method of dysphagia identification based on radiographic
views of chewing and swallowing.
Stuve–Wiedemann syndrome—locus 5p13.1
Stuve–Wiedemann syndrome (SWS) is a rare, genetic
autosomal recessive disease characterised by bone dys-
plasias, respiratory distress, physical disability and early
mortality. Most of the patients suffer from swallowing
difficulties and resulting aspiration pneumonias which are a
key contributor to death among these children [44].
Dagoneau et al. [45] investigated 19 families of SWS
patients. Using a linkage analysis, the authors screened 24
patients with SWS from 19 families and revealed that
chromosomal region 5p13.1 may be involved in the
pathogenesis of this syndrome. Moreover, they analysed in
more detail one of the genes from chromosome 5q13.1—
LIFR and analysed the mRNA transcripts. Most of the
children from analysed families had swallowing problems
with diagnosed dysphagia. Another study on a two-year-
old female with SWS and severe dysphagia confirmed the
mutation in LIFR gene (OMIM 151443) [44]. However,
LIFR is probably not directly associated with swallowing
difficulties because its main function is in bone formation.
Thus, further analysis of other genes from the 5p13.1
chromosomal region should be considered.
CHARGE syndrome—locus 8q12
CHARGE syndrome is a mnemonic for coloboma of the
eye, heart defects, atresia of the choanae, retarded growth
and development, genital and/or urinary abnormalities,
and ear anomalies. CHARGE syndrome is most likely
caused by mutations within the chromosomal region 8q12.
The main features of CHARGE syndrome comprise colo-
boma (abnormality of the eye caused by the missing tissue
of the iris or the retina or the choroid), one- or two-sided
choanal atresia (blocking of the nasal passage), cranial
nerve dysfunction causing hearing and swallowing
impairment, orofacial clefts, developmental delays and
cardiovascular problems.
One study indicated that swallowing problems affect
79 % of children with CHARGE syndrome [46]. The
swallowing impairment was assessed by parental reporting.
A proportion of the cases with swallowing impairment may
be caused by the clef palate which occurs in 20 % of
children affected by the syndrome. Nevertheless, swal-
lowing difficulties lead to more severe feeding difficulties
which remain the leading cause of neonatal death in
CHARGE syndrome. The main gene related to CHARGE
syndrome is the CHD7 gene (OMIM 608892) from the
chromosome 8q12 which encodes Chromodomain Helicase
DNA Binding Protein. The exact mechanisms of the
pathways with CHD7 gene remain unknown. Again, self-
reported swallowing impairments should be evaluated with
more accurate swallowing diagnostic tools with healthcare
professionals.
DiGeorge syndrome—locus 22q11
DiGeorge syndrome is caused by a small deletion of the
chromosome 22q11. Clinical features are difficult to
describe and vary between all individuals, even within the
same family. The main features include heart defects and
orofacial abnormalities. Patients with DiGeorge syndrome
develop autoimmune disorders such as rheumatoid arthri-
tis, breathing and hearing impairments, seizures caused by
low levels of calcium, and gastrointestinal problems such
as dysphagia [47].
VFS studies performed on 75 children with DiGeorge
syndrome [48] identified problems with coordinating the
suck/swallow/breath pattern leading to gagging or regur-
gitation. Karpinski et al. [49] recently developed an animal
model of DiGeorge syndrome; 22q11 knockout mice were
compared with mice with normal genotype and 21 genes
(including COMT gene) were selected for the analysis.
Apart from features such as altered jaw morphology, mice
had swallowing impairments and chest infections caused
by aspiration. Swallowing problems and aspiration were
assessed following death by the presence of milk in the
nose and the sinuses of infant mice. This may be a limi-
tation of the study, because swallowing impairment
assessment in mice and rats is problematic. Mice pups
also had disrupted development of cranial nerves (CN)
crucial for feeding and swallowing (CN X, CN IX, CN X).
Different expression with knockout mice and wild type was
observed in the COMT gene, and therefore may play a role
in cortical plasticity in humans.
In the syndromes above, there are major genetic con-
tributions to the clinical phenotypes. There are also well-
specified regions of the genome implicated as causal in the
problems that patients experience, including swallowing.
One of the limitations of this research is the fact that
swallowing problems within the cohorts of patients with
congenital syndromes might be due to brainstem and/or
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other multifactorial/anatomical problems, with no evidence
of cerebral cortex involvement. Nevertheless, the genetic
loci implicated in this work should be considered in future
experimental work.
Conclusions
This review has explored a number of studies investigating
genetic determinants of swallowing physiology and
pathophysiology and possible responsiveness to treatment.
Due to its complicated physiology, swallowing is most
likely controlled by numerous genes and associated path-
ways. There are, of course, limitations to the available
research. For example, studies using a candidate genetic
analysis experimental approach are limited by the a priori
choice of the genetic marker. As we have limited under-
standing in the mechanisms involved in neurogenic dys-
phagia, the choice of a genetic marker is often made by
extrapolating information from associated phenotypes
which may not be accurate. Nonetheless, the presented
studies show the need for more comparative, integrative
research protocols, consistency of methodological approa-
ches and replication of existing findings in order to identify
robust genetic candidates that may contribute to the neu-
rophysiology of swallowing.
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